Cannabis Friend Or Foe Of Schizophernia
•
5 likes•862 views
The document discusses the relationship between cannabis use and schizophrenia. It reports that cannabis use is associated with younger male schizophrenic patients, longer hospitalizations, and more suicide attempts. While cannabis use may increase psychotic symptoms in those with schizophrenia, one study found it improved cognition. Regular cannabis use has different effects on cognitive function in schizophrenic patients versus healthy controls. Another study found that CBD in cannabis may have antipsychotic and anxiolytic properties and could be a safe alternative treatment for schizophrenia.
Report
Share
Report
Share
![Cannabis Friend or Foe of Schizophrenia! ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recommended
Introductory Psychology: Neuropharmacology III
lecture 9 from a college level introduction to psychology course taught Fall 2011 by Brian J. Piper, Ph.D. (psy391@gmail.com) at Willamette University, includes substituted amphetamines (methamphetamine and MDMA), epidemiology, pharmacokinetics, pharmacodynamics
Methamphetamine Abuse And Clandestine Laboratories
These PowerPoint presentations are intended for use by crime prevention practitioners who bring their experience and expertise to each topic. The presentations are not intended for public use or by individuals with no training or expertise in crime prevention. Each presentation is intended to educate, increase awareness, and teach prevention strategies. Presenters must discern whether their audiences require a more basic or advanced level of information.
NCPC welcomes your input and would like your assistance in tracking the use of these topical presentations. Please email NCPC at trainings@ncpc.org with information about when and how the presentations were used. If you like, we will also place you in a database to receive updates of the PowerPoint presentations and additional training information. We encourage you to visit www.ncpc.org to find additional information on these topics. We also invite you to send in your own trainer notes, handouts, pictures, and anecdotes to share with others on www.ncpc.org.
Recommended
Introductory Psychology: Neuropharmacology III
lecture 9 from a college level introduction to psychology course taught Fall 2011 by Brian J. Piper, Ph.D. (psy391@gmail.com) at Willamette University, includes substituted amphetamines (methamphetamine and MDMA), epidemiology, pharmacokinetics, pharmacodynamics
Methamphetamine Abuse And Clandestine Laboratories
These PowerPoint presentations are intended for use by crime prevention practitioners who bring their experience and expertise to each topic. The presentations are not intended for public use or by individuals with no training or expertise in crime prevention. Each presentation is intended to educate, increase awareness, and teach prevention strategies. Presenters must discern whether their audiences require a more basic or advanced level of information.
NCPC welcomes your input and would like your assistance in tracking the use of these topical presentations. Please email NCPC at trainings@ncpc.org with information about when and how the presentations were used. If you like, we will also place you in a database to receive updates of the PowerPoint presentations and additional training information. We encourage you to visit www.ncpc.org to find additional information on these topics. We also invite you to send in your own trainer notes, handouts, pictures, and anecdotes to share with others on www.ncpc.org.
Is Cannabis A Natural Treatment for Anorexia
People are using weed delivery in Los Angeles to treat anorexia. Mainstream medicine considers this controversial but real evidence is showing changes
Schifano et al. 2015 world psychiatry
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, GABA-A/B receptor agonists, a range of prescribed medications, psychoactive plants/herbs, and a large series of performance and image enhancing drugs. Users are typically attracted by these substances due to their intense psychoactive effects and likely lack of detection in routine drug screenings. This paper aims at providing psychiatrists with updated knowledge of the clinical pharmacology and psychopathological consequences of the use of these substances. Indeed, these drugs act on a range of neurotransmitter pathways/receptors whose imbalance has been associated with psychopathological conditions, including dopamine, cannabinoid CB1, GABA-A/B, 5-HT2A, glutamate, and k opioid receptors. An overall approach in terms of clinical management is briefly discussed.
Hospital and Community Psychiatry October 1989 Vol. 40 No. 10 .docx
Hospital and Community Psychiatry October 1989 Vol. 40 No. 10 1025
dictive Behaviors. Edited by Donovan
DM, Marlart GA. New York, Guilford,
1988
35. Grant I, Reed R: Neuropsychology of
alcohol and drug abuse, in Substance
Abuse and Psychology. Edited by Alter-
man A!. NewYork, Plenum, 1985
36. Vardy MM, Kay SR: LSD psychosis or
LSD-induced schizophrenia? A multi-
method inquiry. Archives of General
Psychiatry 40:877-883, 1983
37. Castellani 5, Petnie WM, Ellinwood E:
Drug-induced psychosis: neurobiologi-
cal mechanisms, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
38. McLellan AT, Woody GE, O’Brien CP:
Development ofpsychiatnic disorders in
drug abusers. New England Journal of
Medicine 301:1310-1314, 1979
39. Ellinwood E, Duarte-Escalante 0:
Chronic methamphetamine intoxication
in three species ofexperimental animals,
in Current Concepts on Amphetamine
Abuse. Edited by Ellinwood E, Cohen S.
Rockville, Md, National Institute of
Mental Health, 1972
40. BeIIDS: The experimental reproduction
of amphetamine psychosis. Archives of
General Psychiatry 30:35-40, 1973
41. Alterman A!: Substance abuse in psychi-
atnic patients, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
42. Kendler KS: A twin study of individuals
with both schizophrenia and alcoholism.
BritishJournal ofPsychiatry 147:48-53,
1985
43. Hesselbrock MN, Hesselbrock VM,
Tennen H, et al: Methodological con-
sidenations in the assessment of depres-
sion in alcoholics. Journal of Consulting
and Clinical Psychology 51:399-405,
1983
44. HimmelhochJM, Hill 5, Steunberg B, et
al: Lithium, alcoholism, and psychiatric
diagnosis. Journal of Psychiatric Treat-
ment and Evaluation 5:83-88, 1983
45. Mayfield D: Substance abuse in theaffec-
sive disorders, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
46. Schuckit MA: The importance of family
history ofaffective disorder in agroup of
young men. Journal of Nervous and
MentalDisease 170:530-535, 1982
47. Robertson MJ: Mental disorder among
homeless persons in the United States:
an overview of recent empirical liters-
tare. Administration in Mental Health
14:14-27, 1986
48. Blashfield BK Propositions regarding
the use of cluster analysis in clinical re-
search.JournalofConsultingand Clinical
Psychology 48:456-459, 1980
49. Blashfield RK, Money LC:The classifica-
tion of depression through cluster anal-
ysis. Comprehensive Psychiatry 20:516-
527, 1979
50. OverallJE, Hollister LE, Johnson M, et
al: Nosology ofdepression and differen-
tial response to drugs. JAMA 195:946-
948, 1966
51. Spitzer RL, Williams JBW: Having a
dream: a research study for DSM-IV.
Archives ofGeneral Psychiatry 45:871-
874, 1988
Treatment of Patients With
Psychiatric and Psychoactive
Substance Abuse Disorders
Fred C. Osher, M.D.
Lial L. Kofoed, M.D.
The treatment ofindividuals with
coexisting psychoactive substance
abuse and severepsy ...
Manajemen Bipolar dengan penggunaan Kanabis
Once again, comorbidity of Bipolar disorder and substance abuse
Pharmacotherapy of Schizophrenia
Clinical manifestations, diagnostic and clinical manifestation of schizophrenia
RIA Neuroscience Study Points to Possible Use of Medical Marijuana for Depres...
Contact information Available pertaining to logged-in reporters onlyCitations Journal of Neuroscienc...
Does Medical Marijuana Work for Depression and Anxiety?
Can marijuana help cure depression and anxiety, read this https://cannabis.net/blog/medical/medical-marijuana-for-depression-and-anxiety
More Related Content
Similar to Cannabis Friend Or Foe Of Schizophernia
Is Cannabis A Natural Treatment for Anorexia
People are using weed delivery in Los Angeles to treat anorexia. Mainstream medicine considers this controversial but real evidence is showing changes
Schifano et al. 2015 world psychiatry
Novel psychoactive substances include synthetic cannabinoids, cathinone derivatives, psychedelic phenethylamines, novel stimulants, synthetic opioids, tryptamine derivatives, phencyclidine-like dissociatives, piperazines, GABA-A/B receptor agonists, a range of prescribed medications, psychoactive plants/herbs, and a large series of performance and image enhancing drugs. Users are typically attracted by these substances due to their intense psychoactive effects and likely lack of detection in routine drug screenings. This paper aims at providing psychiatrists with updated knowledge of the clinical pharmacology and psychopathological consequences of the use of these substances. Indeed, these drugs act on a range of neurotransmitter pathways/receptors whose imbalance has been associated with psychopathological conditions, including dopamine, cannabinoid CB1, GABA-A/B, 5-HT2A, glutamate, and k opioid receptors. An overall approach in terms of clinical management is briefly discussed.
Hospital and Community Psychiatry October 1989 Vol. 40 No. 10 .docx
Hospital and Community Psychiatry October 1989 Vol. 40 No. 10 1025
dictive Behaviors. Edited by Donovan
DM, Marlart GA. New York, Guilford,
1988
35. Grant I, Reed R: Neuropsychology of
alcohol and drug abuse, in Substance
Abuse and Psychology. Edited by Alter-
man A!. NewYork, Plenum, 1985
36. Vardy MM, Kay SR: LSD psychosis or
LSD-induced schizophrenia? A multi-
method inquiry. Archives of General
Psychiatry 40:877-883, 1983
37. Castellani 5, Petnie WM, Ellinwood E:
Drug-induced psychosis: neurobiologi-
cal mechanisms, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
38. McLellan AT, Woody GE, O’Brien CP:
Development ofpsychiatnic disorders in
drug abusers. New England Journal of
Medicine 301:1310-1314, 1979
39. Ellinwood E, Duarte-Escalante 0:
Chronic methamphetamine intoxication
in three species ofexperimental animals,
in Current Concepts on Amphetamine
Abuse. Edited by Ellinwood E, Cohen S.
Rockville, Md, National Institute of
Mental Health, 1972
40. BeIIDS: The experimental reproduction
of amphetamine psychosis. Archives of
General Psychiatry 30:35-40, 1973
41. Alterman A!: Substance abuse in psychi-
atnic patients, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
42. Kendler KS: A twin study of individuals
with both schizophrenia and alcoholism.
BritishJournal ofPsychiatry 147:48-53,
1985
43. Hesselbrock MN, Hesselbrock VM,
Tennen H, et al: Methodological con-
sidenations in the assessment of depres-
sion in alcoholics. Journal of Consulting
and Clinical Psychology 51:399-405,
1983
44. HimmelhochJM, Hill 5, Steunberg B, et
al: Lithium, alcoholism, and psychiatric
diagnosis. Journal of Psychiatric Treat-
ment and Evaluation 5:83-88, 1983
45. Mayfield D: Substance abuse in theaffec-
sive disorders, in Substance Abuse and
Psychology. Edited by Alterman A!.
New York, Plenum, 1985
46. Schuckit MA: The importance of family
history ofaffective disorder in agroup of
young men. Journal of Nervous and
MentalDisease 170:530-535, 1982
47. Robertson MJ: Mental disorder among
homeless persons in the United States:
an overview of recent empirical liters-
tare. Administration in Mental Health
14:14-27, 1986
48. Blashfield BK Propositions regarding
the use of cluster analysis in clinical re-
search.JournalofConsultingand Clinical
Psychology 48:456-459, 1980
49. Blashfield RK, Money LC:The classifica-
tion of depression through cluster anal-
ysis. Comprehensive Psychiatry 20:516-
527, 1979
50. OverallJE, Hollister LE, Johnson M, et
al: Nosology ofdepression and differen-
tial response to drugs. JAMA 195:946-
948, 1966
51. Spitzer RL, Williams JBW: Having a
dream: a research study for DSM-IV.
Archives ofGeneral Psychiatry 45:871-
874, 1988
Treatment of Patients With
Psychiatric and Psychoactive
Substance Abuse Disorders
Fred C. Osher, M.D.
Lial L. Kofoed, M.D.
The treatment ofindividuals with
coexisting psychoactive substance
abuse and severepsy ...
Manajemen Bipolar dengan penggunaan Kanabis
Once again, comorbidity of Bipolar disorder and substance abuse
Pharmacotherapy of Schizophrenia
Clinical manifestations, diagnostic and clinical manifestation of schizophrenia
RIA Neuroscience Study Points to Possible Use of Medical Marijuana for Depres...
Contact information Available pertaining to logged-in reporters onlyCitations Journal of Neuroscienc...
Does Medical Marijuana Work for Depression and Anxiety?
Can marijuana help cure depression and anxiety, read this https://cannabis.net/blog/medical/medical-marijuana-for-depression-and-anxiety
Similar to Cannabis Friend Or Foe Of Schizophernia (20)
Co Morbidity Of Schizophrenia And Other Mental Illnesses
Co Morbidity Of Schizophrenia And Other Mental Illnesses
Hospital and Community Psychiatry October 1989 Vol. 40 No. 10 .docx
Hospital and Community Psychiatry October 1989 Vol. 40 No. 10 .docx
RIA Neuroscience Study Points to Possible Use of Medical Marijuana for Depres...
RIA Neuroscience Study Points to Possible Use of Medical Marijuana for Depres...
Does Medical Marijuana Work for Depression and Anxiety?
Does Medical Marijuana Work for Depression and Anxiety?
Recently uploaded
KDIGO 2024 guidelines for diabetologists
KDIGO guidelines 2024 for evaluation and management of CKD, related to diabetes and management of diabetic kidney disease
Physiology of Chemical Sensation of smell.pdf
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Physiology of Special Chemical Sensation of Taste
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Ocular injury ppt Upendra pal optometrist upums saifai etawah
This ppt are composed by upendra pal to provide help future optometrist of india
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam is an important text for ayurvedic physician belonging to andhra pradehs. It is a popular compendium in various parts of our country as well as in andhra pradesh. The content of the text was presented in sanskrit and telugu language (Bilingual). One of the most famous book in ayurvedic pharmaceutics and therapeutics. This book contains 25 chapters called as prakaranas. Many rasaoushadis were explained, pioneer of dhatu druti, nadi pareeksha, mutra pareeksha etc. Belongs to the period of 15-16 century. New diseases like upadamsha, phiranga rogas are explained.
Effective-Soaps-for-Fungal-Skin-Infections.pptx
Swisschem Dermacare has mentioned the List of The Best Antifungal Soap In India 2022. All of these soaps are trusted by various Dermatology Experts.
Knee anatomy and clinical tests 2024.pdf
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Overall life span (LS) was 1671.7±1721.6 days and cumulative 5YS reached 62.4%, 10 years – 50.4%, 20 years – 44.6%. 94 LCP lived more than 5 years without cancer (LS=2958.6±1723.6 days), 22 – more than 10 years (LS=5571±1841.8 days). 67 LCP died because of LC (LS=471.9±344 days). AT significantly improved 5YS (68% vs. 53.7%) (P=0.028 by log-rank test). Cox modeling displayed that 5YS of LCP significantly depended on: N0-N12, T3-4, blood cell circuit, cell ratio factors (ratio between cancer cells-CC and blood cells subpopulations), LC cell dynamics, recalcification time, heparin tolerance, prothrombin index, protein, AT, procedure type (P=0.000-0.031). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and N0-12 (rank=1), thrombocytes/CC (rank=2), segmented neutrophils/CC (3), eosinophils/CC (4), erythrocytes/CC (5), healthy cells/CC (6), lymphocytes/CC (7), stick neutrophils/CC (8), leucocytes/CC (9), monocytes/CC (10). Correct prediction of 5YS was 100% by neural networks computing (error=0.000; area under ROC curve=1.0).
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
For educational purposes for medical students and registrars in Urology
Non-respiratory Functions of the Lungs.pdf
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
PPT RELATED TO ARTHROLOGY ACCORDING TO NCISM AYURVEDA
Recently uploaded (20)
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
SURGICAL ANATOMY OF THE RETROPERITONEUM, ADRENALS, KIDNEYS AND URETERS.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 9719300533 #ℂall #gIRL in Dehradun
Cannabis Friend Or Foe Of Schizophernia
- 1. Cannabis Friend or Foe of Schizophrenia! A dried flowered bud of the Cannabis sativa plant. Paul Eugen Bleuler (1857–1939) coined the term "Schizophrenia" in 1908